Selected research
Industry Research
Immunoglobulin Products Industry Research Report 2026
Market perspective
The global Immunoglobulin Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Immunoglobulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Immunoglobulin Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Immunoglobulin Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Immunoglobulin Products include Octapharma, Kedrion, Grifols, Emergent Biosolutions, CSL, China Biologic Products, Biotest Pharmaceuticals, Bio Products Laboratory and Bharat Serums and Vaccines, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Immunoglobulin Products market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immunoglobulin Products Market by Company
Octapharma
Kedrion
Grifols
Emergent Biosolutions
CSL
China Biologic Products
Biotest Pharmaceuticals
Bio Products Laboratory
Bharat Serums and Vaccines
Immunoglobulin Products Segment by Type
IG A
IG D
IG E
IG G
IG M
Immunoglobulin Products Segment by Application
CIDP
Myasthenia Gravis
Congenital AIDS
ITP
Immunodeficiency Diseases
CLL
Multifocal Motor Neuropathy
Kawasaki Disease
Hypogammaglobulinemia
Immunoglobulin Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunoglobulin Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunoglobulin Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunoglobulin Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Immunoglobulin Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Immunoglobulin Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Immunoglobulin Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- IG A
- IG D
- IG E
- IG G
- IG M
Applications
- CIDP
- Myasthenia Gravis
- Congenital AIDS
- ITP
- Immunodeficiency Diseases
- CLL
- Multifocal Motor Neuropathy
- Kawasaki Disease
- Hypogammaglobulinemia
Companies covered
- Octapharma
- Kedrion
- Grifols
- Emergent Biosolutions
- CSL
- China Biologic Products
- Biotest Pharmaceuticals
- Bio Products Laboratory
- Bharat Serums and Vaccines
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Immunoglobulin Products Market Size (2021-2032)
- 2.2.2 Global Immunoglobulin Products Sales (2021-2032)
- 2.2.3 Global Immunoglobulin Products Market Average Price (2021-2032)
- 2.3 Immunoglobulin Products by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 IG A
- 2.3.3 IG D
- 2.3.4 IG E
- 2.3.5 IG G
- 2.3.6 IG M
- 2.4 Immunoglobulin Products by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 CIDP
- 2.4.3 Myasthenia Gravis
- 2.4.4 Congenital AIDS
- 2.4.5 ITP
- 2.4.6 Immunodeficiency Diseases
- 2.4.7 CLL
- 2.4.8 Multifocal Motor Neuropathy
- 2.4.9 Kawasaki Disease
- 2.4.10 Hypogammaglobulinemia
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Immunoglobulin Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Immunoglobulin Products Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Immunoglobulin Products Revenue of Manufacturers (2021-2026)
- 3.4 Global Immunoglobulin Products Average Price by Manufacturers (2021-2026)
- 3.5 Global Immunoglobulin Products Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Immunoglobulin Products, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Immunoglobulin Products, Product Type & Application
- 3.8 Global Manufacturers of Immunoglobulin Products, Established Date
- 3.9 Global Immunoglobulin Products Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Octapharma
- 4.1.1 Octapharma Company Information
- 4.1.2 Octapharma Business Overview
- 4.1.3 Octapharma Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Octapharma Immunoglobulin Products Product Portfolio
- 4.1.5 Octapharma Recent Developments
- 4.2 Kedrion
- 4.2.1 Kedrion Company Information
- 4.2.2 Kedrion Business Overview
- 4.2.3 Kedrion Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kedrion Immunoglobulin Products Product Portfolio
- 4.2.5 Kedrion Recent Developments
- 4.3 Grifols
- 4.3.1 Grifols Company Information
- 4.3.2 Grifols Business Overview
- 4.3.3 Grifols Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Grifols Immunoglobulin Products Product Portfolio
- 4.3.5 Grifols Recent Developments
- 4.4 Emergent Biosolutions
- 4.4.1 Emergent Biosolutions Company Information
- 4.4.2 Emergent Biosolutions Business Overview
- 4.4.3 Emergent Biosolutions Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Emergent Biosolutions Immunoglobulin Products Product Portfolio
- 4.4.5 Emergent Biosolutions Recent Developments
- 4.5 CSL
- 4.5.1 CSL Company Information
- 4.5.2 CSL Business Overview
- 4.5.3 CSL Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CSL Immunoglobulin Products Product Portfolio
- 4.5.5 CSL Recent Developments
- 4.6 China Biologic Products
- 4.6.1 China Biologic Products Company Information
- 4.6.2 China Biologic Products Business Overview
- 4.6.3 China Biologic Products Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 China Biologic Products Immunoglobulin Products Product Portfolio
- 4.6.5 China Biologic Products Recent Developments
- 4.7 Biotest Pharmaceuticals
- 4.7.1 Biotest Pharmaceuticals Company Information
- 4.7.2 Biotest Pharmaceuticals Business Overview
- 4.7.3 Biotest Pharmaceuticals Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Biotest Pharmaceuticals Immunoglobulin Products Product Portfolio
- 4.7.5 Biotest Pharmaceuticals Recent Developments
- 4.8 Bio Products Laboratory
- 4.8.1 Bio Products Laboratory Company Information
- 4.8.2 Bio Products Laboratory Business Overview
- 4.8.3 Bio Products Laboratory Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bio Products Laboratory Immunoglobulin Products Product Portfolio
- 4.8.5 Bio Products Laboratory Recent Developments
- 4.9 Bharat Serums and Vaccines
- 4.9.1 Bharat Serums and Vaccines Company Information
- 4.9.2 Bharat Serums and Vaccines Business Overview
- 4.9.3 Bharat Serums and Vaccines Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bharat Serums and Vaccines Immunoglobulin Products Product Portfolio
- 4.9.5 Bharat Serums and Vaccines Recent Developments
5 Global Immunoglobulin Products Market Scenario by Region
- 5.1 Global Immunoglobulin Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Immunoglobulin Products Sales by Region: 2021-2032
- 5.2.1 Global Immunoglobulin Products Sales by Region: 2021-2026
- 5.2.2 Global Immunoglobulin Products Sales by Region: 2027-2032
- 5.3 Global Immunoglobulin Products Revenue by Region: 2021-2032
- 5.3.1 Global Immunoglobulin Products Revenue by Region: 2021-2026
- 5.3.2 Global Immunoglobulin Products Revenue by Region: 2027-2032
- 5.4 North America Immunoglobulin Products Market Facts & Figures by Country
- 5.4.1 North America Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Immunoglobulin Products Sales by Country (2021-2032)
- 5.4.3 North America Immunoglobulin Products Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Immunoglobulin Products Market Facts & Figures by Country
- 5.5.1 Europe Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Immunoglobulin Products Sales by Country (2021-2032)
- 5.5.3 Europe Immunoglobulin Products Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Immunoglobulin Products Market Facts & Figures by Country
- 5.6.1 Asia Pacific Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Immunoglobulin Products Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Immunoglobulin Products Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Immunoglobulin Products Market Facts & Figures by Country
- 5.7.1 South America Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Immunoglobulin Products Sales by Country (2021-2032)
- 5.7.3 South America Immunoglobulin Products Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Immunoglobulin Products Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Immunoglobulin Products Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Immunoglobulin Products Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Immunoglobulin Products Sales by Type (2021-2032)
- 6.1.1 Global Immunoglobulin Products Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Immunoglobulin Products Sales Market Share by Type (2021-2032)
- 6.2 Global Immunoglobulin Products Revenue by Type (2021-2032)
- 6.2.1 Global Immunoglobulin Products Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Immunoglobulin Products Revenue Market Share by Type (2021-2032)
- 6.3 Global Immunoglobulin Products Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Immunoglobulin Products Sales by Application (2021-2032)
- 7.1.1 Global Immunoglobulin Products Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Immunoglobulin Products Sales Market Share by Application (2021-2032)
- 7.2 Global Immunoglobulin Products Revenue by Application (2021-2032)
- 7.2.1 Global Immunoglobulin Products Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Immunoglobulin Products Revenue Market Share by Application (2021-2032)
- 7.3 Global Immunoglobulin Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Immunoglobulin Products Value Chain Analysis
- 8.1.1 Immunoglobulin Products Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Immunoglobulin Products Production Mode & Process
- 8.2 Immunoglobulin Products Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Immunoglobulin Products Distributors
- 8.2.3 Immunoglobulin Products Customers
9 Global Immunoglobulin Products Analyzing Market Dynamics
- 9.1 Immunoglobulin Products Industry Trends
- 9.2 Immunoglobulin Products Industry Drivers
- 9.3 Immunoglobulin Products Industry Opportunities and Challenges
- 9.4 Immunoglobulin Products Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst